Ad
related to: Novavax
Search results
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 7 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 7 days agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 4 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 3 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 2 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 10 hours agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 4 days agoNovavax, Inc.’s recently made public that its President, R&D Dubovsky Filip unloaded Company’s shares for reported $0.66 million on May 14 ’24. In the deal valued at $13.90 ...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 3 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via Yahoo Finance· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Shah Capital ends campaign against Novavax board after Sanofi deal By Reuters
Investing.com· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...